Delivery Order SPE2DE21D7020-SPE2D624F99CT
- Not listed
- This is a federal contract award to Boston Scientific Corp (doing business as Boston Scientific), a leading manufacturer of medical devices, by the Defense Logistics Agency (DLA). The $1,700.16 fixed-price delivery order is for the supply of 4566758090 AMPLATZ SS 75CM .035 (BX/5) medical devices. The contract has an ultimate completion date of December 26, 2024. This award is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract, potentially indicating Boston Scientific's role...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices, for the supply of AMPLATZ S/S GW/035/145 (BX/5) medical devices. The $1,062.60 fixed-price contract has an ultimate completion date of August 7, 2024. This award is not associated with a set-aside program. Boston Scientific, also doing business as Boston Scientific, is a for-profit organization and manufacturer of goods that has received numerous federal...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, doing business as Boston Scientific. The contract is for the delivery of 4,566,117,765 units of AMPLATZ SS 75CM .035 medical devices, which are likely used for cardiovascular or peripheral vascular procedures. The contract has a ceiling value of $3,398.48 and was awarded on October 16, 2024 with a final completion date of October 23, 2024. The contract type is fixed-price with...
- This federal contract award, SPE2DE21D7020|SPE2D624F0ND6, is a delivery order placed by the Defense Logistics Agency (DLA) with Boston Scientific Corporation, a leading manufacturer of medical devices. The contract, valued at $1,275.12, is for the delivery of 4564980541 AMPLATZ SS 75CM .035 (BX/5) medical devices. This is not a set-aside contract. The contract has a completion date of June 28, 2024. Boston Scientific has been awarded several federal contracts and sub-awards, including a $295...
- The U.S. government awarded a delivery order contract to Boston Scientific Corporation, a leading medical device manufacturer, to supply 4564941087 AMPLATZ S/S XCH/035/180 (BX/5) products. The $1,591.60 fixed-price contract with economic price adjustment was issued by the Defense Logistics Agency, a defense agency that provides worldwide logistics support. The contract has an ultimate completion date of June 26, 2024. Boston Scientific, doing business as Boston Scientific, is a for-profit...
- This is a $1,062.60 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices, under contract number SPE2DE21D7020. The contract is for the delivery of AMPLATZ SS 75CM .035 medical devices, which are used in various clinical applications. This is not a set-aside contract. Boston Scientific has previously received multiple federal contract awards and sub-awards, including a $295 million indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Boston Scientific Corporation, a leading manufacturer of medical devices. The $1,592.52 fixed-price contract with economic price adjustment is for the supply of AMPLATZ S/S XCH/035/260 (BX/5) medical devices. The award has an ultimate completion date of August 26, 2024. This delivery order is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle, though the original...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $1,050.45, is for the delivery of AMPLATZ S/S XCH/035/180 (BX/5) medical devices. The contract does not have a set-aside designation and has a performance period through March 18, 2025. Boston Scientific, as the prime contractor, will be providing these specialized cardiovascular medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a for-profit medical device manufacturer headquartered in Marlborough, Massachusetts. The contract, valued at $1,700.16, is for the supply of AMPLATZ S/S GW/035/145 (BX/5) medical devices. The contract has a fixed price with economic price adjustment pricing type and a performance period through February 3, 2025. It is not a set-aside contract. This contract appears to be a...
- This is a fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company, for the provision of AMPLATZ SS 75CM .035 (BX/5) medical devices. The contract has a ceiling value of $3,740.32 and a performance period through July 16, 2025. The contract is not set aside for any specific business type, indicating Boston Scientific competed in the open market. Boston Scientific is a key supplier of advanced medical equipment...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D624F99CTDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, doing business as Boston Scientific, a leading medical device manufacturer. The contract is for the supply of 4563934320 AMPLATZ SS 75CM .035 (BX/5) medical devices, with a total ceiling value of $1,187.06. The contract is a fixed-price with economic price adjustment and has an ultimate completion date of March 19, 2024. This award is not associated with a set-aside program. Boston Scientific has been awarded multiple federal contracts and subcontracts, including a $295 million single-award indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Veterans Affairs (VA) for surgical implants and related services, as well as a $3.5 million IDIQ for TheraSphere Y-90 radioactive microspheres used in interventional radiology treatments. The company has also received grant sub-awards for research and development of bioelectronic medicine approaches, demonstrating its involvement in advancing cutting-edge medical technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/12/24 |